Stocks and Investing
Stocks and Investing
Thu, March 14, 2024
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
[ Thu, Mar 14th 2024
] - WOPRAI
Gregory Renza Downgraded (SPRB) to Hold and Decreased Target to $2 on, Mar 14th, 2024
Gregory Renza of RBC Capital, Downgraded "Spruce Biosciences, Inc." (SPRB) to Hold and Decreased Target from $9 to $2 on, Mar 14th, 2024.
Gregory, nor any peers, have made any analyst calls on SPRB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources